Literature DB >> 34772920

Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties.

Nathan Riguet1, Anne-Laure Mahul-Mellier1, Niran Maharjan1, Johannes Burtscher1, Marie Croisier2, Graham Knott2, Janna Hastings1,3, Alice Patin1, Veronika Reiterer4, Hesso Farhan4, Sergey Nasarov1, Hilal A Lashuel5.   

Abstract

Despite the strong evidence linking the aggregation of the Huntingtin protein (Htt) to the pathogenesis of Huntington's disease (HD), the mechanisms underlying Htt aggregation and neurodegeneration remain poorly understood. Herein, we investigated the ultrastructural properties and protein composition of Htt cytoplasmic and nuclear inclusions in mammalian cells and primary neurons overexpressing mutant exon1 of the Htt protein. Our findings provide unique insight into the ultrastructural properties of cytoplasmic and nuclear Htt inclusions and their mechanisms of formation. We show that Htt inclusion formation and maturation are complex processes that, although initially driven by polyQ-dependent Htt aggregation, also involve the polyQ and PRD domain-dependent sequestration of lipids and cytoplasmic and cytoskeletal proteins related to HD dysregulated pathways; the recruitment and accumulation of remodeled or dysfunctional membranous organelles, and the impairment of the protein quality control and degradation machinery. We also show that nuclear and cytoplasmic Htt inclusions exhibit distinct biochemical compositions and ultrastructural properties, suggesting different mechanisms of aggregation and toxicity.
© 2021. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34772920      PMCID: PMC8589980          DOI: 10.1038/s41467-021-26684-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  149 in total

Review 1.  Loss of normal huntingtin function: new developments in Huntington's disease research.

Authors:  E Cattaneo; D Rigamonti; D Goffredo; C Zuccato; F Squitieri; S Sipione
Journal:  Trends Neurosci       Date:  2001-03       Impact factor: 13.837

2.  IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.

Authors:  Leslie Michels Thompson; Charity T Aiken; Linda S Kaltenbach; Namita Agrawal; Katalin Illes; Ali Khoshnan; Marta Martinez-Vincente; Montserrat Arrasate; Jacqueline Gire O'Rourke; Hasan Khashwji; Tamas Lukacsovich; Ya-Zhen Zhu; Alice L Lau; Ashish Massey; Michael R Hayden; Scott O Zeitlin; Steven Finkbeiner; Kim N Green; Frank M LaFerla; Gillian Bates; Lan Huang; Paul H Patterson; Donald C Lo; Ana Maria Cuervo; J Lawrence Marsh; Joan S Steffan
Journal:  J Cell Biol       Date:  2009-12-21       Impact factor: 10.539

3.  Neurocognitive signs in prodromal Huntington disease.

Authors:  Julie C Stout; Jane S Paulsen; Sarah Queller; Andrea C Solomon; Kathryn B Whitlock; J Colin Campbell; Noelle Carlozzi; Kevin Duff; Leigh J Beglinger; Douglas R Langbehn; Shannon A Johnson; Kevin M Biglan; Elizabeth H Aylward
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

Review 4.  The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.

Authors:  James R Arndt; Maxmore Chaibva; Justin Legleiter
Journal:  Biomol Concepts       Date:  2015-03

Review 5.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

6.  A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.

Authors:  B Kremer; P Goldberg; S E Andrew; J Theilmann; H Telenius; J Zeisler; F Squitieri; B Lin; A Bassett; E Almqvist
Journal:  N Engl J Med       Date:  1994-05-19       Impact factor: 91.245

7.  Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity.

Authors:  Randy Singh Atwal; Jianrun Xia; Deborah Pinchev; Jillian Taylor; Richard M Epand; Ray Truant
Journal:  Hum Mol Genet       Date:  2007-08-18       Impact factor: 6.150

8.  In Situ Architecture and Cellular Interactions of PolyQ Inclusions.

Authors:  Felix J B Bäuerlein; Itika Saha; Archana Mishra; Maria Kalemanov; Antonio Martínez-Sánchez; Rüdiger Klein; Irina Dudanova; Mark S Hipp; F Ulrich Hartl; Wolfgang Baumeister; Rubén Fernández-Busnadiego
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

9.  Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract.

Authors:  Koning Shen; Barbara Calamini; Jonathan A Fauerbach; Boxue Ma; Sarah H Shahmoradian; Ivana L Serrano Lachapel; Wah Chiu; Donald C Lo; Judith Frydman
Journal:  Elife       Date:  2016-10-18       Impact factor: 8.140

10.  Molecular and structural architecture of polyQ aggregates in yeast.

Authors:  Anselm Gruber; Daniel Hornburg; Matthias Antonin; Natalie Krahmer; Javier Collado; Miroslava Schaffer; Greta Zubaite; Christian Lüchtenborg; Timo Sachsenheimer; Britta Brügger; Matthias Mann; Wolfgang Baumeister; F Ulrich Hartl; Mark S Hipp; Rubén Fernández-Busnadiego
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

View more
  4 in total

1.  HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington's disease pathogenesis.

Authors:  Shiyu Xu; Gang Li; Xin Ye; Dongsheng Chen; Zhihua Chen; Zhen Xu; Moretti Daniele; Sara Tambone; Alessandra Ceccacci; Licia Tomei; Lili Ye; Yue Yu; Amanda Solbach; Stephen M Farmer; Erin Furr Stimming; George McAllister; Deanna M Marchionini; Sheng Zhang
Journal:  PLoS Genet       Date:  2022-07-19       Impact factor: 6.020

2.  A FRET-based method for monitoring structural transitions in protein self-organization.

Authors:  Qi Wan; Sara N Mouton; Liesbeth M Veenhoff; Arnold J Boersma
Journal:  Cell Rep Methods       Date:  2022-03-28

Review 3.  Implementing Complementary Approaches to Shape the Mechanism of α-Synuclein Oligomerization as a Model of Amyloid Aggregation.

Authors:  Marco Giampà; María J Amundarain; Maria Georgina Herrera; Nicolò Tonali; Veronica I Dodero
Journal:  Molecules       Date:  2021-12-24       Impact factor: 4.411

4.  Non-monotonic fibril surface occlusion by GFP tags from coarse-grained molecular simulations.

Authors:  Julian C Shillcock; Janna Hastings; Nathan Riguet; Hilal A Lashuel
Journal:  Comput Struct Biotechnol J       Date:  2021-12-15       Impact factor: 7.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.